STOCK TITAN

Senti Biosciences audit committee approves KNAV as auditor

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Senti Biosciences Holdings, Inc. (SNTI) dismissed KPMG LLP as its independent registered public accounting firm effective November 17, 2026, with Audit Committee approval. On November 20, 2026, the committee approved KNAV CPA LLP as the new independent auditor for the fiscal year ending December 31, 2026.

KPMG’s audit reports for 2025 and 2024 included substantial-doubt language about the company’s ability to continue as a going concern, citing recurring losses, negative cash flows from operations and an accumulated deficit. The company reported no disagreements with KPMG. Management concluded that a material weakness in internal control identified as of December 31, 2024, was remediated during 2025.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 2 points

How the balance works

Positive

  • None.

Negative

  • Major point2025 and 2024 audit reports included substantial-doubt language.
  • Minor pointA material weakness existed at year-end 2024; management concluded it was remediated during 2025.
Item 4.01 Changes in Registrant's Certifying Accountant Governance
The company changed its independent auditing firm, which may involve disagreements on accounting matters.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
KPMG dismissal effective date November 17, 2026 Effective date of the dismissal
KNAV engagement approval date November 20, 2026 Audit Committee approval
Fiscal year covered by KNAV engagement Year ending December 31, 2026 SNTI’s new independent auditor
going concern financial
"substantial doubt about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
material weakness financial
"material weakness in the Company’s internal control over financial reporting"
A material weakness is a significant flaw in the systems and checks a company uses to ensure its financial reports are accurate, meaning errors or fraud could happen and not be caught. For investors it matters because it raises the risk that reported results are unreliable—similar to finding a hole in a ship’s hull—potentially leading to corrected financials, regulatory action, reduced trust, and negative effects on stock value and borrowing costs.
reportable events regulatory
"no “reportable events”"
Reportable events are significant incidents or changes a company is legally required to disclose to regulators and the public, such as major safety problems, legal actions, financial irregularities, or management changes. They matter to investors because these events can alter a company’s risk profile or future performance, much like a dashboard warning light signals a problem that could affect a car’s safety or reliability. Timely disclosure helps investors make informed decisions and maintain market fairness.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is SNTI’s new independent auditor?

KNAV CPA LLP was approved as SNTI’s new independent registered public accounting firm for the fiscal year ending December 31, 2026.

Did SNTI report disagreements with KPMG?

No disagreements were reported on accounting principles or practices, financial statement disclosure, or audit scope or procedure during the fiscal years ended December 31, 2025 and 2024 and the subsequent interim period through November 17, 2026.

What did KPMG’s SNTI audit reports say about going concern?

The reports for fiscal years 2025 and 2024 included explanatory paragraphs expressing substantial doubt about SNTI’s ability to continue as a going concern. The stated factors were recurring losses, negative cash flows from operations and an accumulated deficit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001854270FALSE00018542702026-11-172026-11-17











UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 17, 2026
___________________________________
SENTI BIOSCIENCES HOLDINGS, INC.
(Exact name of Registrant as specified in its charter)
___________________________________
Delaware001-4044042-1912154
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
2 Corporate Drive, First Floor
South San Francisco, California 94080
(Address of principal executive offices including zip code)
Registrant’s telephone number, including area code: (650) 239-2030


(Former name or former address, if changed since last report)
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Common stock, $0.0001 par value per shareSNTI
The Nasdaq Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 4.01. Changes in Registrant’s Certifying Accountant.

(a) Dismissal of Independent Registered Public Accounting Firm

KPMG LLP (“KPMG”) previously served as the independent registered public accounting firm of Senti Biosciences Holdings, Inc. (the “Company”) and, prior to the Company’s holding company reorganization effective April 24, 2026, of Senti Biosciences, Inc. (“Former Senti”), to which the Company is the successor issuer pursuant to Rule 12g-3(a) under the Securities Exchange Act of 1934, as amended. References to the Company for periods prior to April 24, 2026 refer to Former Senti.

On November 17, 2026, the Company informed KPMG that it was dismissing KPMG as the Company’s independent registered public accounting firm, effective as of that date. The decision to dismiss KPMG was approved by the Audit Committee of the Board of Directors of the Company (the “Audit Committee”).

KPMG’s audit reports on the Company’s consolidated financial statements as of and for the fiscal years ended December 31, 2025 and 2024 did not contain an adverse opinion or a disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope, or accounting principles, except that such reports contained an explanatory paragraph regarding substantial doubt about the Company’s ability to continue as a going concern due to the Company’s recurring losses, negative cash flows from operations, and accumulated deficit.

During the fiscal years ended December 31, 2025 and 2024 and the subsequent interim period through November 17, 2026, there were (i) no “disagreements” (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) between the Company and KPMG on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which, if not resolved to the satisfaction of KPMG, would have caused KPMG to make reference to the subject matter of the disagreements in connection with its reports on the Company’s consolidated financial statements for such years, and (ii) no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K), except for the material weakness in the Company’s internal control over financial reporting that existed as of December 31, 2024, as previously disclosed in Part II, Item 9A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The material weakness related to a lack of sufficient and adequate resources in the finance and accounting function that resulted in ineffective process level control activities over non-routine, unusual, or complex transactions. As disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, management concluded that the material weakness was remediated during the year ended December 31, 2025.

The Audit Committee discussed the subject matter of the material weakness described above with KPMG. The Company has authorized KPMG to respond fully to the inquiries of KNAV (as defined below), as the Company’s successor independent registered public accounting firm, concerning the subject matter of the material weakness.

The Company provided KPMG with a copy of the disclosures made in this Current Report on Form 8-K prior to its filing with the Securities and Exchange Commission (the “SEC”) and requested that KPMG furnish the Company with a letter addressed to the SEC stating whether it agrees with the statements made above and, if not, stating the respects in which it does not agree. A copy of KPMG’s letter is filed as Exhibit 16.1 to this Current Report on Form 8-K.

(b) Engagement of New Independent Registered Public Accounting Firm

On November 20, 2026, the Audit Committee approved the engagement of KNAV CPA LLP (“KNAV”) as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2026. During the fiscal years ended December 31, 2025 and 2024 and the subsequent interim period prior to the engagement of KNAV, neither the Company nor anyone acting on its behalf consulted with KNAV regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s consolidated financial statements, and neither a written report nor oral advice was provided to the Company that KNAV concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue, or (ii) any matter that was either the subject of a disagreement or a reportable event.


Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.Description
16.1
Letter from KPMG LLP to the Securities and Exchange Commission, dated November 20, 2026.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SENTI BIOSCIENCES HOLDINGS, INC.
Date:November 20, 2026By:/s/ Timothy Lu, M.D., Ph.D.
Name:Timothy Lu, M.D., Ph.D.
Title:Chief Executive Officer


Filing Exhibits & Attachments

4 documents

Keep reading